Disclosures for "Peripheral Sphingolipids as Potential Biomarkers of Parkinson disease Including Sex-Related Differences ")
-
Roberto Ortega has nothing to disclose.
-
Prof. Burbulla has nothing to disclose.
-
Izolda Mileva has nothing to disclose.
-
Mr. Taylor has nothing to disclose.
-
Dr. Cuperlovic-Culf has nothing to disclose.
-
Ms. Glickman has nothing to disclose.
-
The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
-
Dr. Scherzer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Scherzer has received research support from NIH. The institution of Dr. Scherzer has received research support from Michael J. Fox Foundation. The institution of Dr. Scherzer has received research support from American Parkinson's Disease Association. Dr. Scherzer has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Ms. Raymond has received research support from NIH.
-
Gabriel Miltenyi-Miltenberger has nothing to disclose.
-
Dr. Yoo has nothing to disclose.
-
William Nichols has nothing to disclose.
-
Dr. Krainc has nothing to disclose.
-
The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
-
Lina Obeid has nothing to disclose.
-
Yusuf Hannun, 9207 has nothing to disclose.
-
The institution of Dr. Bennett has received research support from Prevail.
-
The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.